{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:48:56Z","timestamp":1791676136446,"version":"4.3.4"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"St Vincent's Institute Rising Star"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"DOI":"10.1007\/s10741-026-10683-7","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:22:55Z","timestamp":1791181375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering the geriatric heart to model HFpEF"],"prefix":"10.1007","volume":"31","author":[{"given":"Sebastian","family":"Bass-Stringer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarmon G.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiang Y.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"10683_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","volume":"329","author":"MM Redfield","year":"2023","unstructured":"Redfield MM, Borlaug BA (2023) Heart Failure With Preserved Ejection Fraction: A Review. JAMA 329:827\u2013838. https:\/\/doi.org\/10.1001\/jama.2023.2020","journal-title":"JAMA"},{"key":"10683_CR2","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G et al (2021) Empagliflozin in Heart Failure with a Preserved Ejection Fraction. N Engl J Med 385:1451\u20131461. https:\/\/doi.org\/10.1056\/NEJMoa2107038","journal-title":"N Engl J Med"},{"key":"10683_CR3","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","volume":"387","author":"SD Solomon","year":"2022","unstructured":"Solomon SD, McMurray JJV, Claggett B et al (2022) Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med 387:1089\u20131098. https:\/\/doi.org\/10.1056\/NEJMoa2206286","journal-title":"N Engl J Med"},{"key":"10683_CR4","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","volume":"391","author":"SD Solomon","year":"2024","unstructured":"Solomon SD, McMurray JJV, Vaduganathan M et al (2024) Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction. N Engl J Med 391:1475\u20131485. https:\/\/doi.org\/10.1056\/NEJMoa2407107","journal-title":"N Engl J Med"},{"key":"10683_CR5","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2410027","volume":"392","author":"M Packer","year":"2025","unstructured":"Packer M, Zile MR, Kramer CM et al (2025) Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity. N Engl J Med 392:427\u2013437. https:\/\/doi.org\/10.1056\/NEJMoa2410027","journal-title":"N Engl J Med"},{"key":"10683_CR6","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1093\/eurheartj\/ehab389","volume":"42","author":"C Withaar","year":"2021","unstructured":"Withaar C, Lam CSP, Schiattarella GG, de Boer RA, Meems LMG (2021) Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models. Eur Heart J 42:4420\u20134430. https:\/\/doi.org\/10.1093\/eurheartj\/ehab389","journal-title":"Eur Heart J"},{"key":"10683_CR7","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","volume":"359","author":"BM Massie","year":"2008","unstructured":"Massie BM, Carson PE, McMurray JJ et al (2008) Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 359:2456\u20132467. https:\/\/doi.org\/10.1056\/NEJMoa0805450","journal-title":"N Engl J Med"},{"key":"10683_CR8","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/jama.2013.2024","volume":"309","author":"MM Redfield","year":"2013","unstructured":"Redfield MM, Chen HH, Borlaug BA et al (2013) Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA 309:1268\u20131277. https:\/\/doi.org\/10.1001\/jama.2013.2024","journal-title":"JAMA"},{"key":"10683_CR9","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1056\/NEJMoa1510774","volume":"373","author":"MM Redfield","year":"2015","unstructured":"Redfield MM, Anstrom KJ, Levine JA et al (2015) Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. N Engl J Med 373:2314\u20132324. https:\/\/doi.org\/10.1056\/NEJMoa1510774","journal-title":"N Engl J Med"},{"key":"10683_CR10","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1001\/jama.2018.14852","volume":"320","author":"BA Borlaug","year":"2018","unstructured":"Borlaug BA, Anstrom KJ, Lewis GD et al (2018) Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial. JAMA 320:1764\u20131773. https:\/\/doi.org\/10.1001\/jama.2018.14852","journal-title":"JAMA"},{"key":"10683_CR11","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nm1175","volume":"11","author":"E Takimoto","year":"2005","unstructured":"Takimoto E, Champion HC, Li M et al (2005) Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy. Nat Med 11:214\u2013222. https:\/\/doi.org\/10.1038\/nm1175","journal-title":"Nat Med"},{"key":"10683_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.115.018935","volume":"133","author":"YC Lai","year":"2016","unstructured":"Lai YC, Tabima DM, Dube JJ et al (2016) SIRT3-AMP-Activated Protein Kinase Activation by Nitrite and Metformin Improves Hyperglycemia and Normalizes Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction. Circulation 133:717\u2013731. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.018935","journal-title":"Circulation"},{"key":"10683_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1161\/01.cir.0000030181.63741.56","volume":"106","author":"S Kagiyama","year":"2002","unstructured":"Kagiyama S, Eguchi S, Frank GD, Inagami T, Zhang YC, Phillips MI (2002) Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense. Circulation 106:909\u2013912. https:\/\/doi.org\/10.1161\/01.cir.0000030181.63741.56","journal-title":"Circulation"},{"key":"10683_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrcardio.2017.65","volume":"14","author":"SM Dunlay","year":"2017","unstructured":"Dunlay SM, Roger VL, Redfield MM (2017) Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 14:591\u2013602. https:\/\/doi.org\/10.1038\/nrcardio.2017.65","journal-title":"Nat Rev Cardiol"},{"key":"10683_CR15","doi-asserted-by":"publisher","first-page":"e018574","DOI":"10.1161\/JAHA.120.018574","volume":"10","author":"Y Sotomi","year":"2021","unstructured":"Sotomi Y, Hikoso S, Nakatani D et al (2021) Sex Differences in Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc 10:e018574. https:\/\/doi.org\/10.1161\/JAHA.120.018574","journal-title":"J Am Heart Assoc"},{"key":"10683_CR16","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","volume":"403","author":"P Campbell","year":"2024","unstructured":"Campbell P, Rutten FH, Lee MM, Hawkins NM, Petrie MC (2024) Heart failure with preserved ejection fraction: everything the clinician needs to know. Lancet 403:1083\u20131092. https:\/\/doi.org\/10.1016\/S0140-6736(23)02756-3","journal-title":"Lancet"},{"key":"10683_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3389\/fphys.2012.00345","volume":"3","author":"S Kaese","year":"2012","unstructured":"Kaese S, Verheule S (2012) Cardiac electrophysiology in mice: a matter of size. Front Physiol 3:345. https:\/\/doi.org\/10.3389\/fphys.2012.00345","journal-title":"Front Physiol"},{"key":"10683_CR18","doi-asserted-by":"publisher","first-page":"17224","DOI":"10.1073\/pnas.1413624111","volume":"111","author":"S Lin","year":"2014","unstructured":"Lin S, Lin Y, Nery JR et al (2014) Comparison of the transcriptional landscapes between human and mouse tissues. Proc Natl Acad Sci U S A 111:17224\u201317229. https:\/\/doi.org\/10.1073\/pnas.1413624111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10683_CR19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/s44161-025-00669-3","volume":"4","author":"MW Pocock","year":"2025","unstructured":"Pocock MW, Reid JD, Robinson HR et al (2025) Maturation of human cardiac organoids enables complex disease modeling and drug discovery. Nat Cardiovasc Res 4:821\u2013840. https:\/\/doi.org\/10.1038\/s44161-025-00669-3","journal-title":"Nat Cardiovasc Res"},{"key":"10683_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","volume":"131","author":"SJ Shah","year":"2015","unstructured":"Shah SJ, Katz DH, Selvaraj S et al (2015) Phenomapping for novel classification of heart failure with preserved ejection fraction. Circulation 131:269\u2013279. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.010637","journal-title":"Circulation"},{"key":"10683_CR21","doi-asserted-by":"publisher","first-page":"i115","DOI":"10.1093\/eurheartjsupp\/suae095","volume":"27","author":"GB Bonfioli","year":"2025","unstructured":"Bonfioli GB, Pagnesi M, Calo L, Metra M (2025) Towards a phenotype profiling of the patients with heart failure and preserved ejection fraction. Eur Heart J Suppl 27:i115\u2013i121. https:\/\/doi.org\/10.1093\/eurheartjsupp\/suae095","journal-title":"Eur Heart J Suppl"},{"key":"10683_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","volume":"20","author":"CH Wong","year":"2019","unstructured":"Wong CH, Siah KW, Lo AW (2019) Estimation of clinical trial success rates and related parameters. Biostatistics 20:273\u2013286. https:\/\/doi.org\/10.1093\/biostatistics\/kxx069","journal-title":"Biostatistics"},{"key":"10683_CR23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","volume":"47","author":"JA DiMasi","year":"2016","unstructured":"DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: New estimates of R&D costs. J Health Econ 47:20\u201333. https:\/\/doi.org\/10.1016\/j.jhealeco.2016.01.012","journal-title":"J Health Econ"},{"key":"10683_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jchf.2013.10.006","volume":"2","author":"J Butler","year":"2014","unstructured":"Butler J, Fonarow GC, Zile MR et al (2014) Developing therapies for heart failure with preserved ejection fraction: current state and future directions. JACC Heart Fail 2:97\u2013112. https:\/\/doi.org\/10.1016\/j.jchf.2013.10.006","journal-title":"JACC Heart Fail"},{"key":"10683_CR25","unstructured":"Towards Healthcare (2024) Organ on a chip market size to expect USD 3242.34 Mn by 2034. Towards Healthcare. https:\/\/www.towardshealthcare.com\/insights\/organ-on-a-chip-market-sizing"},{"key":"10683_CR26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.amjmed.2023.03.033","volume":"136","author":"EY Adashi","year":"2023","unstructured":"Adashi EY, O\u2019Mahony DP, Cohen IG (2023) The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional. Am J Med 136:853\u2013854. https:\/\/doi.org\/10.1016\/j.amjmed.2023.03.033","journal-title":"Am J Med"},{"key":"10683_CR27","doi-asserted-by":"publisher","first-page":"e70046","DOI":"10.1002\/cpdd.70046","volume":"15","author":"MJ Fossler","year":"2026","unstructured":"Fossler MJ, Garner CE (2026) The FDA Roadmap to Reducing Animal Testing in Preclinical Safety Studies: Where Will It Lead Us? Clin Pharmacol Drug Dev 15:e70046. https:\/\/doi.org\/10.1002\/cpdd.70046","journal-title":"Clin Pharmacol Drug Dev"},{"issue":"8","key":"10683_CR28","doi-asserted-by":"publisher","first-page":"2178","DOI":"10.1016\/j.tibtech.2025.12.011","volume":"44","author":"S Gerke","year":"2026","unstructured":"Gerke S, Balamut J, Wagner JK (2026) The FDA\u2019s plan to phase out animal testing. Trends Biotechnol 44:2178\u20132181. https:\/\/doi.org\/10.1016\/j.tibtech.2025.12.011","journal-title":"Trends Biotechnol"},{"key":"10683_CR29","unstructured":"U.S. Food and Drug Administration (2025) Roadmap to reducing animal testing in preclinical safety studies. U.S. Food and Drug Administration. https:\/\/www.fda.gov\/files\/newsroom\/published\/roadmap_to_reducing_animal_testing_in_preclinical_safety_studies.pdf"},{"key":"10683_CR30","unstructured":"Department for Science, Innovation and Technology (2025) Replacing animals in science: a strategy to support the development, validation and uptake of alternative methods. UK Government's Department for Science, Innovation and Technology. https:\/\/www.gov.uk\/government\/publications\/replacing-animals-in-science-strategy\/replacing-animals-in-science-a-strategy-to-support-the-development-validation-and-uptake-of-alternative-methods"},{"key":"10683_CR31","unstructured":"European_Commission (2026) Roadmap towards phasing out animal testing for chemical safety assessments Brussels: European Commission. https:\/\/single-market-economy.ec.europa.eu\/publications\/roadmap-towards-phasing-out-animal-testing-chemical-safety-assessments_en"},{"key":"10683_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.pharmthera.2013.10.007","volume":"141","author":"N Milani-Nejad","year":"2014","unstructured":"Milani-Nejad N, Janssen PM (2014) Small and large animal models in cardiac contraction research: advantages and disadvantages. Pharmacol Ther 141:235\u2013249. https:\/\/doi.org\/10.1016\/j.pharmthera.2013.10.007","journal-title":"Pharmacol Ther"},{"key":"10683_CR33","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2013-14-10-r115","volume":"14","author":"S Horvath","year":"2013","unstructured":"Horvath S (2013) DNA methylation age of human tissues and cell types. Genome Biol 14:R115. https:\/\/doi.org\/10.1186\/gb-2013-14-10-r115","journal-title":"Genome Biol"},{"key":"10683_CR34","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","volume":"184","author":"P Hofbauer","year":"2021","unstructured":"Hofbauer P, Jahnel SM, Papai N et al (2021) Cardioids reveal self-organizing principles of human cardiogenesis. Cell 184:3299\u20133317e22. https:\/\/doi.org\/10.1016\/j.cell.2021.04.034","journal-title":"Cell"},{"key":"10683_CR35","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.116.024145","volume":"135","author":"M Tiburcy","year":"2017","unstructured":"Tiburcy M, Hudson JE, Balfanz P et al (2017) Defined Engineered Human Myocardium With Advanced Maturation for Applications in Heart Failure Modeling and Repair. Circulation 135:1832\u20131847. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024145","journal-title":"Circulation"},{"key":"10683_CR36","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.stemcr.2016.04.011","volume":"7","author":"I Mannhardt","year":"2016","unstructured":"Mannhardt I, Breckwoldt K, Letuffe-Breniere D et al (2016) Human Engineered Heart Tissue: Analysis of Contractile Force. Stem Cell Rep 7:29\u201342. https:\/\/doi.org\/10.1016\/j.stemcr.2016.04.011","journal-title":"Stem Cell Rep"},{"key":"10683_CR37","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.stem.2025.09.011","volume":"32","author":"C O\u2019Hern","year":"2025","unstructured":"O\u2019Hern C, Caywood S, Aminova S et al (2025) Human heart-macrophage assembloids mimic immune-cardiac interactions and enable arrhythmia disease modeling. Cell Stem Cell 32:1671\u20131690e13. https:\/\/doi.org\/10.1016\/j.stem.2025.09.011","journal-title":"Cell Stem Cell"},{"key":"10683_CR38","doi-asserted-by":"publisher","first-page":"e047429","DOI":"10.1161\/JAHA.125.047429","volume":"15","author":"Y Huang","year":"2026","unstructured":"Huang Y, Luo L, Ma X et al (2026) Macrophage-Dependent Intercellular Crosstalk in Multiphenotypic Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc 15:e047429. https:\/\/doi.org\/10.1161\/JAHA.125.047429","journal-title":"J Am Heart Assoc"},{"key":"10683_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2026.06.007","author":"H Tani","year":"2026","unstructured":"Tani H, Haga K, Moriwaki T et al (2026) Human iPSC-derived engineered heart tissue model of diastolic dysfunction in heart failure with preserved ejection fraction. Cell Stem Cell. https:\/\/doi.org\/10.1016\/j.stem.2026.06.007","journal-title":"Cell Stem Cell"},{"key":"10683_CR40","doi-asserted-by":"publisher","first-page":"E8372","DOI":"10.1073\/pnas.1707316114","volume":"114","author":"RJ Mills","year":"2017","unstructured":"Mills RJ, Titmarsh DM, Koenig X et al (2017) Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc Natl Acad Sci U S A 114:E8372\u2013E8381. https:\/\/doi.org\/10.1073\/pnas.1707316114","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10683_CR41","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller JD, Ganat YM, Kishinevsky S et al (2013) Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13:691\u2013705. https:\/\/doi.org\/10.1016\/j.stem.2013.11.006","journal-title":"Cell Stem Cell"},{"key":"10683_CR42","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1242\/dev.120667","volume":"142","author":"E Vera","year":"2015","unstructured":"Vera E, Studer L (2015) When rejuvenation is a problem: challenges of modeling late-onset neurodegenerative disease. Development 142:3085\u20133089. https:\/\/doi.org\/10.1242\/dev.120667","journal-title":"Development"},{"key":"10683_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","volume":"17","author":"J Mertens","year":"2015","unstructured":"Mertens J, Paquola ACM, Ku M et al (2015) Directly Reprogrammed Human Neurons Retain Aging-Associated Transcriptomic Signatures and Reveal Age-Related Nucleocytoplasmic Defects. Cell Stem Cell 17:705\u2013718. https:\/\/doi.org\/10.1016\/j.stem.2015.09.001","journal-title":"Cell Stem Cell"},{"key":"10683_CR44","doi-asserted-by":"publisher","first-page":"723","DOI":"10.14670\/HH-18-458","volume":"37","author":"YX Zhang","year":"2022","unstructured":"Zhang YX, Chen SL, Li YM, Zheng YW (2022) Limitations and challenges of direct cell reprogramming in vitro and in vivo. Histol Histopathol 37:723\u2013737. https:\/\/doi.org\/10.14670\/HH-18-458","journal-title":"Histol Histopathol"},{"key":"10683_CR45","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1089\/scd.2012.0490","volume":"22","author":"SD Lundy","year":"2013","unstructured":"Lundy SD, Zhu WZ, Regnier M, Laflamme MA (2013) Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. Stem Cells Dev 22:1991\u20132002. https:\/\/doi.org\/10.1089\/scd.2012.0490","journal-title":"Stem Cells Dev"},{"key":"10683_CR46","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1126\/science.1127168","volume":"312","author":"P Scaffidi","year":"2006","unstructured":"Scaffidi P, Misteli T (2006) Lamin A-dependent nuclear defects in human aging. Science 312:1059\u20131063. https:\/\/doi.org\/10.1126\/science.1127168","journal-title":"Science"},{"key":"10683_CR47","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/CIRCULATIONAHA.109.902056","volume":"121","author":"CD Ragnauth","year":"2010","unstructured":"Ragnauth CD, Warren DT, Liu Y et al (2010) Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 121:2200\u20132210. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.902056","journal-title":"Circulation"},{"key":"10683_CR48","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nrm.2017.68","volume":"18","author":"N Kubben","year":"2017","unstructured":"Kubben N, Misteli T (2017) Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases. Nat Rev Mol Cell Biol 18:595\u2013609. https:\/\/doi.org\/10.1038\/nrm.2017.68","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10683_CR49","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G (2023) Hallmarks of aging: An expanding universe. Cell 186:243\u2013278. https:\/\/doi.org\/10.1016\/j.cell.2022.11.001","journal-title":"Cell"},{"key":"10683_CR50","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/agm2.70041","volume":"8","author":"J Kadiwala","year":"2025","unstructured":"Kadiwala J, Shakur R (2025) Generation of Nonintegrative-Induced Pluripotent Stem Cells in Hutchinson-Gilford Progeria Syndrome: Enhancing Aging Research. Aging Med (Milton) 8:493\u2013498. https:\/\/doi.org\/10.1002\/agm2.70041","journal-title":"Aging Med (Milton)"},{"key":"10683_CR51","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09879","volume":"472","author":"GH Liu","year":"2011","unstructured":"Liu GH, Barkho BZ, Ruiz S et al (2011) Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome. Nature 472:221\u2013225. https:\/\/doi.org\/10.1038\/nature09879","journal-title":"Nature"},{"key":"10683_CR52","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1038\/s42003-024-07273-4","volume":"7","author":"K Barmpa","year":"2024","unstructured":"Barmpa K, Saraiva C, Lopez-Pigozzi D et al (2024) Modeling early phenotypes of Parkinson\u2019s disease by age-induced midbrain-striatum assembloids. Commun Biol 7:1561. https:\/\/doi.org\/10.1038\/s42003-024-07273-4","journal-title":"Commun Biol"},{"key":"10683_CR53","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.celrep.2016.09.062","volume":"17","author":"E Vera","year":"2016","unstructured":"Vera E, Bosco N, Studer L (2016) Generating Late-Onset Human iPSC-Based Disease Models by Inducing Neuronal Age-Related Phenotypes through Telomerase Manipulation. Cell Rep 17:1184\u20131192. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.062","journal-title":"Cell Rep"},{"key":"10683_CR54","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe JP, Patil CK, Rodier F et al (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6:2853\u20132868. https:\/\/doi.org\/10.1371\/journal.pbio.0060301","journal-title":"PLoS Biol"},{"key":"10683_CR55","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1056\/NEJMcp1511175","volume":"375","author":"MM Redfield","year":"2016","unstructured":"Redfield MM (2016) Heart Failure with Preserved Ejection Fraction. N Engl J Med 375:1868\u20131877. https:\/\/doi.org\/10.1056\/NEJMcp1511175","journal-title":"N Engl J Med"},{"key":"10683_CR56","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/CIRCHEARTFAILURE.112.970061","volume":"5","author":"CS Lam","year":"2012","unstructured":"Lam CS, Carson PE, Anand IS et al (2012) Sex differences in clinical characteristics and outcomes in elderly patients with heart failure and preserved ejection fraction: the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial. Circ Heart Fail 5:571\u2013578. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.112.970061","journal-title":"Circ Heart Fail"},{"key":"10683_CR57","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","volume":"568","author":"GG Schiattarella","year":"2019","unstructured":"Schiattarella GG, Altamirano F, Tong D et al (2019) Nitrosative stress drives heart failure with preserved ejection fraction. Nature 568:351\u2013356. https:\/\/doi.org\/10.1038\/s41586-019-1100-z","journal-title":"Nature"},{"key":"10683_CR58","doi-asserted-by":"publisher","first-page":"1850200","DOI":"10.1155\/crp\/1850200","volume":"2025","author":"J Cheng","year":"2025","unstructured":"Cheng J, Li Y, Shen S et al (2025) Estrogen Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis. Cardiol Res Pract 2025:1850200. https:\/\/doi.org\/10.1155\/crp\/1850200","journal-title":"Cardiol Res Pract"},{"key":"10683_CR59","doi-asserted-by":"publisher","first-page":"e60189","DOI":"10.1371\/journal.pone.0060189","volume":"8","author":"X Liu","year":"2013","unstructured":"Liu X, Chen B, Chen L et al (2013) U-shape suppressive effect of phenol red on the epileptiform burst activity via activation of estrogen receptors in primary hippocampal culture. PLoS ONE 8:e60189. https:\/\/doi.org\/10.1371\/journal.pone.0060189","journal-title":"PLoS ONE"},{"key":"10683_CR60","doi-asserted-by":"publisher","first-page":"e43569","DOI":"10.7759\/cureus.43569","volume":"15","author":"A Raj","year":"2023","unstructured":"Raj A, Chakole S, Agrawal S et al (2023) The Impact of Menopause on Cardiovascular Aging: A Comprehensive Review of Androgen Influences. Cureus 15:e43569. https:\/\/doi.org\/10.7759\/cureus.43569","journal-title":"Cureus"},{"key":"10683_CR61","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.stem.2012.02.014","volume":"10","author":"S Mekhoubad","year":"2012","unstructured":"Mekhoubad S, Bock C, de Boer AS, Kiskinis E, Meissner A, Eggan K (2012) Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 10:595\u2013609. https:\/\/doi.org\/10.1016\/j.stem.2012.02.014","journal-title":"Cell Stem Cell"},{"key":"10683_CR62","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.stem.2012.03.008","volume":"11","author":"MC Anguera","year":"2012","unstructured":"Anguera MC, Sadreyev R, Zhang Z et al (2012) Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell 11:75\u201390. https:\/\/doi.org\/10.1016\/j.stem.2012.03.008","journal-title":"Cell Stem Cell"},{"key":"10683_CR63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1152\/physiolgenomics.00133.2024","volume":"57","author":"MA Lopez-Pier","year":"2025","unstructured":"Lopez-Pier MA, Marino VA, Vazquez-Loreto AC et al (2025) Myocardial transcriptomic and proteomic landscapes across the menopausal continuum in a murine model of chemically induced accelerated ovarian failure. Physiol Genomics 57:409\u2013430. https:\/\/doi.org\/10.1152\/physiolgenomics.00133.2024","journal-title":"Physiol Genomics"},{"key":"10683_CR64","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jsbmb.2005.04.025","volume":"95","author":"RJ Santen","year":"2005","unstructured":"Santen RJ, Song RX, Zhang Z et al (2005) Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment. J Steroid Biochem Mol Biol 95:155\u2013165. https:\/\/doi.org\/10.1016\/j.jsbmb.2005.04.025","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10683_CR65","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/toxsci\/kfy239","volume":"167","author":"J Huo","year":"2019","unstructured":"Huo J, Wei F, Cai C, Lyn-Cook B, Pang L (2019) Sex-Related Differences in Drug-Induced QT Prolongation and Torsades de Pointes: A New Model System with Human iPSC-CMs. Toxicol Sci 167:360\u2013374. https:\/\/doi.org\/10.1093\/toxsci\/kfy239","journal-title":"Toxicol Sci"},{"key":"10683_CR66","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1161\/01.hyp.31.1.522","volume":"31","author":"RK Dubey","year":"1998","unstructured":"Dubey RK, Gillespie DG, Jackson EK, Keller PJ (1998) 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 31:522\u2013528. https:\/\/doi.org\/10.1161\/01.hyp.31.1.522","journal-title":"Hypertension"},{"key":"10683_CR67","doi-asserted-by":"publisher","first-page":"107387","DOI":"10.1016\/j.pharmthera.2019.06.009","volume":"203","author":"ME Moss","year":"2019","unstructured":"Moss ME, Carvajal B, Jaffe IZ (2019) The endothelial mineralocorticoid receptor: Contributions to sex differences in cardiovascular disease. Pharmacol Ther 203:107387. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.06.009","journal-title":"Pharmacol Ther"},{"key":"10683_CR68","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1161\/CIRCULATIONAHA.117.032474","volume":"137","author":"M Packer","year":"2018","unstructured":"Packer M (2018) Leptin-Aldosterone-Neprilysin Axis: Identification of Its Distinctive Role in the Pathogenesis of the Three Phenotypes of Heart Failure in People With Obesity. Circulation 137:1614\u20131631. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.032474","journal-title":"Circulation"},{"key":"10683_CR69","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1056\/NEJMoa032566","volume":"350","author":"MR Zile","year":"2004","unstructured":"Zile MR, Baicu CF, Gaasch WH (2004) Diastolic heart failure\u2013abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 350:1953\u20131959. https:\/\/doi.org\/10.1056\/NEJMoa032566","journal-title":"N Engl J Med"},{"key":"10683_CR70","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","volume":"126","author":"AJ Engler","year":"2006","unstructured":"Engler AJ, Sen S, Sweeney HL, Discher DE (2006) Matrix elasticity directs stem cell lineage specification. Cell 126:677\u2013689. https:\/\/doi.org\/10.1016\/j.cell.2006.06.044","journal-title":"Cell"},{"key":"10683_CR71","doi-asserted-by":"publisher","first-page":"H2196","DOI":"10.1152\/ajpheart.01017.2005","volume":"290","author":"MF Berry","year":"2006","unstructured":"Berry MF, Engler AJ, Woo YJ et al (2006) Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290:H2196\u2013H2203. https:\/\/doi.org\/10.1152\/ajpheart.01017.2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10683_CR72","doi-asserted-by":"publisher","first-page":"1576824","DOI":"10.3389\/fbioe.2025.1576824","volume":"13","author":"I Gisone","year":"2025","unstructured":"Gisone I, Boffito M, Persiani E et al (2025) Integration of co-culture conditions and 3D gelatin methacryloyl hydrogels to improve human-induced pluripotent stem cells-derived cardiomyocytes maturation. Front Bioeng Biotechnol 13:1576824. https:\/\/doi.org\/10.3389\/fbioe.2025.1576824","journal-title":"Front Bioeng Biotechnol"},{"key":"10683_CR73","doi-asserted-by":"publisher","first-page":"31296","DOI":"10.1039\/d5ra04674b","volume":"15","author":"LF Arrieta-Viana","year":"2025","unstructured":"Arrieta-Viana LF, Mendez-Vega J, Torres-Lugo M (2025) Synthetic thermoresponsive scaffolds for the expansion and differentiation of human pluripotent stem cells into cardiomyocytes. RSC Adv 15:31296\u201331312. https:\/\/doi.org\/10.1039\/d5ra04674b","journal-title":"RSC Adv"},{"key":"10683_CR74","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.actbio.2015.06.031","volume":"24","author":"G Sommer","year":"2015","unstructured":"Sommer G, Schriefl AJ, Andra M et al (2015) Biomechanical properties and microstructure of human ventricular myocardium. Acta Biomater 24:172\u2013192. https:\/\/doi.org\/10.1016\/j.actbio.2015.06.031","journal-title":"Acta Biomater"},{"key":"10683_CR75","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1007\/s12551-021-00838-1","volume":"13","author":"R Emig","year":"2021","unstructured":"Emig R, Zgierski-Johnston CM, Timmermann V et al (2021) Passive myocardial mechanical properties: meaning, measurement, models. Biophys Rev 13:587\u2013610. https:\/\/doi.org\/10.1007\/s12551-021-00838-1","journal-title":"Biophys Rev"},{"key":"10683_CR76","doi-asserted-by":"publisher","first-page":"e019338","DOI":"10.1161\/JAHA.120.019338","volume":"10","author":"C Hall","year":"2021","unstructured":"Hall C, Gehmlich K, Denning C, Pavlovic D (2021) Complex Relationship Between Cardiac Fibroblasts and Cardiomyocytes in Health and Disease. J Am Heart Assoc 10:e019338. https:\/\/doi.org\/10.1161\/JAHA.120.019338","journal-title":"J Am Heart Assoc"},{"key":"10683_CR77","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41569-025-01162-x","volume":"22","author":"A Pasut","year":"2025","unstructured":"Pasut A, Lama E, Van Craenenbroeck AH, Kroon J, Carmeliet P (2025) Endothelial cell metabolism in cardiovascular physiology and disease. Nat Rev Cardiol 22:923\u2013943. https:\/\/doi.org\/10.1038\/s41569-025-01162-x","journal-title":"Nat Rev Cardiol"},{"key":"10683_CR78","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.7150\/ijbs.49871","volume":"16","author":"Y Zhuge","year":"2020","unstructured":"Zhuge Y, Zhang J, Qian F et al (2020) Role of smooth muscle cells in Cardiovascular Disease. Int J Biol Sci 16:2741\u20132751. https:\/\/doi.org\/10.7150\/ijbs.49871","journal-title":"Int J Biol Sci"},{"key":"10683_CR79","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1016\/j.stem.2024.05.011","volume":"31","author":"S Landau","year":"2024","unstructured":"Landau S, Zhao Y, Hamidzada H et al (2024) Primitive macrophages enable long-term vascularization of human heart-on-a-chip platforms. Cell Stem Cell 31:1222\u20131238e10. https:\/\/doi.org\/10.1016\/j.stem.2024.05.011","journal-title":"Cell Stem Cell"},{"key":"10683_CR80","doi-asserted-by":"publisher","first-page":"1550226","DOI":"10.3389\/fimmu.2025.1550226","volume":"16","author":"B Mo","year":"2025","unstructured":"Mo B, Ding Y, Ji Q (2025) NLRP3 inflammasome in cardiovascular diseases: an update. Front Immunol 16:1550226. https:\/\/doi.org\/10.3389\/fimmu.2025.1550226","journal-title":"Front Immunol"},{"key":"10683_CR81","doi-asserted-by":"publisher","unstructured":"Lewis-Israeli YR, Wasserman AH, Aguirre A (2021) Heart organoids and engineered heart tissues: novel tools for modeling human cardiac biology and disease. Biomolecules 11:1277. https:\/\/doi.org\/10.3390\/biom11091277","DOI":"10.3390\/biom11091277"},{"key":"10683_CR82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41378-024-00751-z","volume":"11","author":"W Wang","year":"2025","unstructured":"Wang W, Su W, Han J et al (2025) Microfluidic platforms for monitoring cardiomyocyte electromechanical activity. Microsyst Nanoeng 11:4. https:\/\/doi.org\/10.1038\/s41378-024-00751-z","journal-title":"Microsyst Nanoeng"},{"key":"10683_CR83","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1038\/s41467-022-34860-y","volume":"13","author":"Q Lyu","year":"2022","unstructured":"Lyu Q, Gong S, Lees JG et al (2022) A soft and ultrasensitive force sensing diaphragm for probing cardiac organoids instantaneously and wirelessly. Nat Commun 13:7259. https:\/\/doi.org\/10.1038\/s41467-022-34860-y","journal-title":"Nat Commun"},{"key":"10683_CR84","doi-asserted-by":"publisher","first-page":"116752","DOI":"10.1016\/j.bios.2024.116752","volume":"267","author":"J Yin","year":"2025","unstructured":"Yin J, Lees JG, Gong S et al (2025) Real-time electro-mechanical profiling of dynamically beating human cardiac organoids by coupling resistive skins with microelectrode arrays. Biosens Bioelectron 267:116752. https:\/\/doi.org\/10.1016\/j.bios.2024.116752","journal-title":"Biosens Bioelectron"},{"key":"10683_CR85","doi-asserted-by":"publisher","unstructured":"Meli VS, Atcha H, Veerasubramanian PK et al (2020) YAP-mediated mechanotransduction tunes the macrophage inflammatory response. Sci Adv 6:eabb8471. https:\/\/doi.org\/10.1126\/sciadv.abb8471","DOI":"10.1126\/sciadv.abb8471"},{"key":"10683_CR86","doi-asserted-by":"publisher","unstructured":"Volpato V, Webber C (2020) Addressing variability in iPSC-derived models of human disease: guidelines to promote reproducibility. Dis Model Mech 13:dmm042317. https:\/\/doi.org\/10.1242\/dmm.042317","DOI":"10.1242\/dmm.042317"},{"key":"10683_CR87","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/CIRCULATIONAHA.120.050498","volume":"143","author":"VS Hahn","year":"2021","unstructured":"Hahn VS, Knutsdottir H, Luo X et al (2021) Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction. Circulation 143:120\u2013134. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050498","journal-title":"Circulation"},{"key":"10683_CR88","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/s41569-024-01067-1","volume":"22","author":"AU Fayyaz","year":"2025","unstructured":"Fayyaz AU, Eltony M, Prokop LJ et al (2025) Pathophysiological insights into HFpEF from studies of human cardiac tissue. Nat Rev Cardiol 22:90\u2013104. https:\/\/doi.org\/10.1038\/s41569-024-01067-1","journal-title":"Nat Rev Cardiol"},{"key":"10683_CR89","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41569-020-0363-2","volume":"17","author":"BA Borlaug","year":"2020","unstructured":"Borlaug BA (2020) Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol 17:559\u2013573. https:\/\/doi.org\/10.1038\/s41569-020-0363-2","journal-title":"Nat Rev Cardiol"},{"key":"10683_CR90","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41551-022-00882-6","volume":"6","author":"K Ronaldson-Bouchard","year":"2022","unstructured":"Ronaldson-Bouchard K, Teles D, Yeager K et al (2022) A multi-organ chip with matured tissue niches linked by vascular flow. Nat Biomed Eng 6:351\u2013371. https:\/\/doi.org\/10.1038\/s41551-022-00882-6","journal-title":"Nat Biomed Eng"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10741-026-10683-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-026-10683-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:04:59Z","timestamp":1791673499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10741-026-10683-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10683"],"URL":"https:\/\/doi.org\/10.1007\/s10741-026-10683-7","relation":{},"ISSN":["1573-7322"],"issn-type":[{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original version of this paper was updated to correct the author's email address from mlim@svi.edi.au to mlim@svi.edu.au.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"During the preparation of this manuscript, the author(s) used Gemini for proofreading and language editing. Additionally, it was used to generate some initial icons for Figure 1, which were subsequently edited by the author(s) to construct the final schematic. The author(s) reviewed and revised all AI-assisted content and take full responsibility for the originality, accuracy, and integrity of the final publication.","order":1,"name":"Ethics","label":"Disclosure statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"111"}}